Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
Guoxu Zheng, Lintao Jia, Angang Yang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24

Showing 24 citing articles:

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 102
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
Xiaofan Wu, Hongjian Yang, Xingfei Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy
Muhua Chen, Lei Bie, Ying Jieer
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115514-115514
Open Access | Times Cited: 22
Peptide drugs: a new direction in cancer immunotherapy
Xinghua Sui, Xiaoshuang Niu, Xiuman Zhou, et al.
Cancer Biology and Medicine (2023), pp. 1-6
Open Access | Times Cited: 14
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Unveiling the key mechanisms of FOLR2+ macrophage-mediated antitumor immunity in breast cancer using integrated single-cell RNA sequencing and bulk RNA sequencing
Sixuan Wu, Jiang Baohong, Zhimin Li, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
HLA-G 3’UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis
Jun Gan, Xing-Hong Di, Zi-Yi Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
Andra Krauze, Yingdong Zhao, Ming‐Chung Li, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1499-1499
Open Access | Times Cited: 7
Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer
Davide Massa, Anna Tosi, Antonio Rosato, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4885-4885
Open Access | Times Cited: 10
Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells
Anna Palau, Filip Segerberg, Michael Lidschreiber, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1830-1841
Open Access | Times Cited: 5
The prognostic genes model of breast cancer drug resistance based on single-cell sequencing analysis and transcriptome analysis
Yao Liu, Lun Dong, Jing Ma, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Construction and validation of a SASP‐related prognostic signature in patients with acute myeloid leukaemia
M. Li, Donghui Zhang, Lisi Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 1
LncRNA ZNF649-AS1 promotes trastuzumab resistance and TAM-dependent PD-L1 expression in breast cancer by regulating EXOC7 alternative splicing
Huaying Dong, Jing Han, Xiang Chen, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110128-110128
Closed Access | Times Cited: 1
Resistance mechanisms and prospects of trastuzumab
Lizhe Wang, Yu Wang, Y Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
Jingjie Guo, Yongqin Ye, Yidi Liu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Dimerization of Transmembrane Proteins in Cancer Immunotherapy
Lei Li, Jingying Li
Membranes (2023) Vol. 13, Iss. 4, pp. 393-393
Open Access | Times Cited: 2
Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis
Yingying Zhang, Siying He, Lisha Yu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Immunological tolerance in breast cancer: some reasons for development
Е. V. Kayukova, E. S. Bolotov
Advances in molecular oncology (2024) Vol. 11, Iss. 3, pp. 24-31
Open Access
Integrated bioinformatics analysis and validation identify KIR2DL4 as a novel biomarker for predicting chemotherapy resistance and prognosis in Colorectal Cancer
HuiE Zhuang, Yizhen Chen
Heliyon (2024) Vol. 10, Iss. 18, pp. e37896-e37896
Open Access
Establishment and verification of a prognostic immune cell signature-based model for breast cancer overall survival
Hailong Liu, Hongguang Bao, Jingying Zhao, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5600-5615
Open Access
Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage
A. Canossi, Anna Aureli, Tiziana Del Beato, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 7, pp. 920-930
Closed Access | Times Cited: 1
HLA-G 14 bp Ins/Del (rs66554220) Variant Is Not Associated with Breast Cancer in Women from Western Mexico
Denisse Stephania Becerra‐Loaiza, Luisa Fernanda Roldan Flores, Luis Antonio Ochoa‐Ramírez, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 8, pp. 6842-6850
Open Access | Times Cited: 1
FOLR2-Positive Macrophages Suppress Breast Cancer Invasion Through T Cell Activation
Baohong Jiang, Sixuan Wu, Yuanbin Tang, et al.
(2023)
Closed Access
Determination of soluble HLA-G serum levels in patients with adenomyosis and uterine fibroids before and after surgery
Yunkai Xie, Yixuan Gao, Wei Liu, et al.
Human Immunology (2023) Vol. 84, Iss. 8, pp. 418-422
Closed Access
Page 1

Scroll to top